About Adnexus
Adnexus is a company based in Waltham (United States) founded in 2002 was acquired by Bristol-Myers Squibb in September 2007.. Adnexus has raised $42.5 million across 2 funding rounds from investors including Flagship Pioneering, Atlas Venture and Bristol-Myers Squibb.
- Headquarter Waltham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42.5 M (USD)
in 2 rounds
-
Latest Funding Round
$15.5 M (USD), Series C
Aug 07, 2007
-
Investors
Flagship Pioneering
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Bristol-Myers Squibb
(Sep 24, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
394 people
Software Development Team
340 people
Senior Team
99 people
Product Management Team
97 people
Operations Team
83 people
Data Analysis and Operations Team
60 people
Sales and Marketing
58 people
Human Resources and Administration
45 people
Unlock access to complete
Funding Insights of Adnexus
Adnexus has successfully raised a total of $42.5M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $15.5 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $15.5M
-
First Round
First Round
(26 Jun 2006)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2007 | Amount | Series C - Adnexus | Valuation |
investors |
|
| Jun, 2006 | Amount | Series B - Adnexus | Valuation | Venrock |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adnexus
Adnexus has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Flagship Pioneering, Atlas Venture and Bristol-Myers Squibb. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adnexus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adnexus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adnexus Comparisons
Competitors of Adnexus
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Adnexus
When was Adnexus founded?
Adnexus was founded in 2002 and raised its 1st funding round 4 years after it was founded.
Where is Adnexus located?
Adnexus is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Is Adnexus a funded company?
Adnexus is a funded company, having raised a total of $42.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $27M, raised on Jun 26, 2006.
What does Adnexus do?
Adnexus Therapeutics was founded in 2002 in Waltham, United States, focusing on the biotechnology sector. Biologics in the therapeutic class are discovered, developed, and distributed within the country for oncology, immunology, and cardiovascular treatments. Product candidates such as AngioceptCT-322, an anti-angiogenesis agent that blocks the VEGFR-2 pathway for cancer, and additional Adnectin therapies are included in the pipeline. Acquisition by Bristol-Myers Squibb occurred in September 2009.
Who are Adnexus's investors?
Adnexus has 6 investors. Key investors include Flagship Pioneering, Atlas Venture, Bristol-Myers Squibb, HBM Healthcare Investments, and Polaris Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.